Immunic is trading 5.1% down at $13.55 today, driven by ongoing downside technical pressure and a cautious broader market sentiment.
- The stock has faced consecutive declines over the past week, retreating from levels above $15.00 on relatively weak momentum.
- There are no fresh company-specific catalysts, such as earnings reports, FDA decisions, or major analyst updates, to account for today's move.